PriceTargets.com logo

Assure - IONM Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $25.33
  • Forecasted Upside: 2,335.90%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.04 As of 05/26/2023 04:59 PM ET
+0 (0.00%)

This chart shows the closing price for IONM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Assure Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IONM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IONM

Analyst Price Target is $25.33
▲ +2,335.90% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Assure in the last 3 months. The average price target is $25.33, with a high forecast of $60.00 and a low forecast of $4.00. The average price target represents a 2,335.90% upside from the last price of $1.04.

This chart shows the closing price for IONM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Assure.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/23/2023BenchmarkLower Target$8.00 ➝ $4.00Low
4/12/2023Roth MkmLower TargetBuy$60.00 ➝ $12.00Low
11/28/2022Roth CapitalLower Target$110.00 ➝ $60.00Low
6/14/2022Roth CapitalInitiated CoverageBuy$110.00High
5/18/2022BenchmarkLower TargetBuy$180.00 ➝ $120.00High
4/5/2022BenchmarkInitiated CoverageBuy$180.00N/A
(Data available from 5/30/2018 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/1/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/31/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/30/2023
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/1/2023
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/31/2023
  • 3 very positive mentions
  • 8 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/30/2023
  • 3 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2023

Current Sentiment

  • 3 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Assure logo
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. The company has operations in Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah, the United States. Assure Holdings Corp. is based in Englewood, Colorado.
Read More

Today's Range

Now: $1.04
Low: $1.04
High: $1.08

50 Day Range

MA: $2.47
Low: $0.96
High: $3.85

52 Week Range

Now: $1.04
Low: $0.93
High: $113.00

Volume

89,600 shs

Average Volume

328,049 shs

Market Capitalization

$1.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Assure?

The following Wall Street research analysts have issued reports on Assure in the last year: Benchmark Co., Roth Capital, and Roth Mkm.
View the latest analyst ratings for IONM.

What is the current price target for Assure?

3 Wall Street analysts have set twelve-month price targets for Assure in the last year. Their average twelve-month price target is $25.33, suggesting a possible upside of 2,335.9%. Roth Capital has the highest price target set, predicting IONM will reach $60.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $4.00 for Assure in the next year.
View the latest price targets for IONM.

What is the current consensus analyst rating for Assure?

Assure currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IONM will outperform the market and that investors should add to their positions of Assure.
View the latest ratings for IONM.

What other companies compete with Assure?

Other companies that are similar to Assure include G Medical Innovations, Quoin Pharmaceuticals, T2 Biosystems, Dynatronics and Motus GI. Learn More about companies similar to Assure.

How do I contact Assure's investor relations team?

Assure's physical mailing address is 4600 S Ulster St Ste 1225, Denver, Colorado 80237. The company's listed phone number is 720-287-3093 and its investor relations email address is [email protected]. The official website for Assure is www.assureneuromonitoring.com. Learn More about contacing Assure investor relations.